Skip to search boxSkip to navigationSkip to main content

Prebiotics, Probiotics, Synbiotics and Functional Foods in Control and Treatment of Type II Diabetes Mellitus and Colorectal Cancer

Research Output:
Chapter in Book/Report/Conference proceeding
Chapter (peer-reviewed)
Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Publication metrics

Abstract

Prebiotics, probiotics and synbiotics are components that enhance human health by several mechanisms. Patients suffering from type II diabetes mellitus (T2DM) and colorectal cancer have seen benefits when treated with a prebiotic, probiotic or synbiotic therapy. These benefits include the improvement of their lipid profile, oxidative stress status, as well as the modulation of the inflammatory and immune responses. The associated benefits of prebiotic, probiotic or synbiotic functional foods have been studied, showing promising results into the prevention or control of diabetes and colorectal cancer. This novelty research provides new evidence that the use of functional foods along with medical therapy could be used to further enhance patient’s health.

Publication Information

Output type

Research Output:
Chapter in Book/Report/Conference proceeding
Chapter (peer-reviewed)
Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 345-362

Publication milestones

  • Published - 27/10/2015

Publication status

Published - 27/10/2015

Publication series

  • Publication series name: Probiotics and Prebiotics in Human Nutrition and Health

Chapter Number

17

Host publication title

Prebiotics, Probiotics, Synbiotics and Functional Foods in Control and Treatment of Type II Diabetes Mellitus and Colorectal Cancer